ClinicalTrials.gg
Not yet recruitingNCT07725744Updated Jul 24, 2026

Interface Pressures, Safety, Adherence, and Tactile Outcomes of Different Pressure Garments After Stroke

An interventional study of Single-Layered 10% Circumferential Reduction (S-10) Pressure Garment and Dorsal-Double-Layered 10% Circumferential Reduction (DD-10) Pressure Garment in CVA (Cerebrovascular Accident) and Stroke, sponsored by National University of Malaysia. Not yet recruiting. Open to participants aged 21 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-07-24.

Sponsored by National University of Malaysia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
21 Years to 60 Years
Sex
All
01

Study summary

This study aims to investigate the interface pressure changes of single-layer with 10% circumferential reduction (S-10), single-layer with 15% circumferential reduction (S-15), and dorsal double-layered with 10% circumferential reduction (DD-10)pressure garments over time, their relationships with adherence and adverse events, and their effects on tactile gnosis.

Participants will:

  1. Wear S-10, S-15, or DD-10 for at least 12 hours daily for four weeks
  2. Measure interface pressure at baseline and weekly
  3. Assess tactile gnosis at baseline, Week 2, and Week 4
  4. Record adherence and adverse events using a self-report logbook
02

Conditions studied

  • CVA (Cerebrovascular Accident)
  • Stroke

Browse trials for

Keywords

  • interface pressure
  • pressure garment
  • pressure changes
  • tactile gnosis
  • adherence
  • safety
  • Stroke Rehabilitation
  • Occupational Therapy
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 33 is below the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

National University of Malaysia is the lead sponsor of 124 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adults aged between 21 years to 60 years old
  • a history of stroke (no restrictions on the stroke type)
  • Modified Ashworth Scale of 1, 1+ or 2 when hand performing flexion and extension
  • no cognitive impairment ( (MoCA ⩾ 21)

Exclusion criteria

Exclusion Criteria:

  • skin lesions, infections or other skin problems
  • serious circulatory problems such as deep vein thrombosis
  • hypersensitive to Lycra materials
  • behavioural disturbances or motor impairments caused by other orthopaedic or neurological conditions other than stroke
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
33 participants (estimated)

Study arms

  • Active comparator
    Single-Layered 10% Circumferential Reduction (S-10) Pressure Garment

    A customized single-layered finger-to-above-elbow (long glove) pressure garment with 10% circumferential reduction.

    Other: Single-Layered 10% Circumferential Reduction (S-10) Pressure Garment

  • Experimental
    Dorsal-Double-Layered 10% Circumferential Reduction (DD-10) Pressure Garment

    A customized finger-to-above-elbow (long glove) pressure garment with 10% of circumferential reduction. The design is similar to S-10 except it has an extra layer of fabric on the dorsal aspect that provides more compression.

    Other: Dorsal-Double-Layered 10% Circumferential Reduction (DD-10) Pressure Garment

  • Active comparator
    Single-Layered 15% Circumferential Reduction (S-15) Pressure Garment

    A customized single-layered finger-to-above-elbow (long glove) pressure garment with 15% circumferential reduction.

    Other: Single-Layered 15% Circumferential Reduction (S-15) Pressure Garment

Interventions

  • OtherSingle-Layered 10% Circumferential Reduction (S-10) Pressure Garment

    Each participant will receive a single-layered 10% circumferential reduction (S-10) pressure garment, fabricated based on their circumferential measurement. Participants will receive standardized verbal and written instructions on prescribed wear schedules, donning and doffing techniques, skin inspection, and hygiene. Caregivers will be trained to assist when required. Participants will be asked to wear the pressure garment daily for at least 6 hours in the day and 6 hours in the evening for 4 weeks, and to record daily wear in a provided logbook. All participants will receive usual stroke rehabilitation in addition to the application of the pressure garment.

  • OtherDorsal-Double-Layered 10% Circumferential Reduction (DD-10) Pressure Garment

    Each participant will receive a dorsal doubled-layered 10% circumferential reduction (DD-10) pressure garment, fabricated based on their circumferential measurement. Participants will receive standardized verbal and written instructions on prescribed wear schedules, donning and doffing techniques, skin inspection, and hygiene. Caregivers will be trained to assist when required. Participants will be asked to wear the pressure garment daily for at least 6 hours in the day and 6 hours in the evening for 4 weeks, and to record daily wear in a provided logbook. All participants will receive usual stroke rehabilitation in addition to the application of the pressure garment.

  • OtherSingle-Layered 15% Circumferential Reduction (S-15) Pressure Garment

    Each participant will receive a single-layered 15% circumferential reduction (S-15) pressure garment, fabricated based on their circumferential measurement. Participants will receive standardized verbal and written instructions on prescribed wear schedules, donning and doffing techniques, skin inspection, and hygiene. Caregivers will be trained to assist when required. Participants will be asked to wear the pressure garment daily for at least 6 hours in the day and 6 hours in the evening for 4 weeks, and to record daily wear in a provided logbook. All participants will receive usual stroke rehabilitation in addition to the application of the pressure garment.

06

What researchers measure

Primary outcomes

  1. Interface pressure measured using PicoPress® Compression System

    The change in interface pressure over time and the group-by-time difference in pressure trajectories among the three pressure garment groups. PicoPress® Compression System is a portable pneumatic measuring system designed to measure interface pressure exerted by pressure garment, medical compression bandage or other compression therapeutic materials.

    Time frame: Baseline, Week-1, Week-2, Week-3, and Week-4

Secondary outcomes

  1. Shape/Texture Identification (STI) test

    A standardized, performance-based test in which participants identify shapes and textures using active touch. It consists of two subsets (i.e., identification of three shapes and identification of three textures) and three difficulty levels (i.e., shape sizes of 15, 8, and 5mm, and distances between dots of 15, 8, 4mm). Each subset is scored from 0 to 3 (one point per size), producing a total score that ranges from 0 to 6. A score of 6 points is interpreted as normal tactile gnosis.

    Time frame: Baseline, Week-2, and Week-4

  2. Daily Self-Report and Adverse Events of Special Interest (AESI) Logbook

    The self-developed logbook is a self-report records that will be used to record the adherence metrics (e.g., daily wear duration, number of days worn per week, reason of non-adherence) and the incidence of adverse events (e.g., incidence, severity, action taken).

    Time frame: Completed by participants or caregiver daily, reviewed weekly by researcher

  3. Modified Ashworth Score (MAS)

    To differentiate between mechanical garment decay and physiological fluctuations in limb volume, muscle tone (spasticity) will be monitored as a potential confounding variable.

    Time frame: Baseline, Week-1, Week-2, Week-3, and Week-4

Other outcomes

  1. Montreal Cognitive Assessment (MoCA) - Bahasa Malaysia version

    A widely used screening tool for detecting cognitive impairment, particularly mild cognitive impairment. It is a 10-minute, 30-point assessment that evaluates various cognitive domains, including working memory, delayed recall, visuospatial abilities, executive functions, attention, concentration, language, and orientation to time and place.

    Time frame: Prior to participant enrolment

  2. Modified Ashworth Score (MAS)

    A method used to assess muscle tone by a scale of 0 to 4, where 0 indicates no spasticity and 4 indicates severe spasticity.

    Time frame: Prior to participant enrolment

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Jan 2027, 6 months later.

Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 6 months is below that.

Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2026
First posted
Jul 24, 2026
StartEst.
Jul 20, 2026
Primary completionEst.
Jan 31, 2027
CompletionEst.
Mar 31, 2027
Last update
Jul 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07725744
Collaborators
SOCSO Rehabilitation Center, Malaysia
Responsible party
Sponsor
First posted
Jul 24, 2026
Start date
Jul 20, 2026 (estimated)
Primary completion
Jan 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Jul 24, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion